OpenVSafe by OpenVAERS
Search V-safe

8VE-97005-64670

2 vaccinations 5 coded responses 23 check-ins 5 free-text entries 1 call case
Sex
Female
Age at first dose
66+
ZIP prefix
358 / AL
Registered
2021-04-12
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-12
    Registered in v-safe
  2. 2021-04-12
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-12
    Survey response — day 0, dose 1
    MedDRA: Balance disorder — Feeling: Good · Fatigue or tiredness
    Free text: A little off balance -may be allergies
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-04-13
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pre-existing disease — Feeling: Good · Site: Pain · Fever · Fatigue or tiredness
    Free text: I responded to this survey because I have systemic mastocytosis. There is very little data available for those of us with this condition. By premedicating I think I've done well.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-04-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-16
    Survey response — days 1–6 daily, dose 1
    MedDRA: Hypersensitivity — Feeling: Fair
    Free text: Allergies not associated with vaccine I suspect.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-04-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-19
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-26
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-05-03
    Dose 2 — Pfizer-BioNTech
  12. 2021-05-03
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-05-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Joint pains, Muscle or body aches
    Adult check-in
  14. 2021-05-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-05-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-05-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Joint pains, Muscle or body aches
    Adult check-in
  17. 2021-05-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-05-10
    Health check-in — day 7, dose 2
    Feeling: Fair · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Adult check-in
  19. 2021-05-17
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-05-24
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-31
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-06-07
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-06-14
    Survey response — day 42, dose 2
    MedDRA: Myeloproliferative neoplasm, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities
    Free text: I've been diagnosed with myeloproliferative neoplasm. This added to my systemic mastocytosis is frustrating.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-08-02
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-11-01
    Survey response — 6 months, dose 2
    MedDRA: Myeloproliferative neoplasm, Office visit, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Diagnosed with myeloproliferative neoplasm - treating with hydroxyurea. I already had systemic mastocytosis - so now take two pills instead of one · Healthcare visit (other): Regular monthly appointment with oncologist
    MedDRA releases: 2024-11 · check-in free text available
  26. 2021-11-01
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  27. 2021-11-03
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  28. 2022-05-05
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-12Pfizer-BioNTech
22021-05-03Pfizer-BioNTech

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 7 — day 0, dose 1

2021-04-12

Systemic reaction (other): A little off balance -may be allergies

Release 7 — days 1–6 daily, dose 1

2021-04-13

Systemic reaction (other): I responded to this survey because I have systemic mastocytosis. There is very little data available for those of us with this condition. By premedicating I think I've done well.

2021-04-16

Systemic reaction (other): Allergies not associated with vaccine I suspect.

Release 9 — day 42, dose 2

2021-06-14

Symptoms: I've been diagnosed with myeloproliferative neoplasm. This added to my systemic mastocytosis is frustrating.

Release 10 — 6 months, dose 2

2021-11-01

Symptoms: Diagnosed with myeloproliferative neoplasm - treating with hydroxyurea. I already had systemic mastocytosis - so now take two pills instead of one
Healthcare visit (other): Regular monthly appointment with oncologist

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDMyeloproliferative neoplasm ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SROBalance disorder ✓ ✓ ✓
SROHypersensitivity ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release